Your browser doesn't support javascript.
loading
Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer.
Yu, Jiwoong; Kwon, Young Suk; Kim, Sinae; Han, Christopher Sejong; Farber, Nicholas; Kim, Jongmyung; Byun, Seok Soo; Kim, Wun-Jae; Jeon, Seong Soo; Kim, Isaac Yi.
Afiliación
  • Yu J; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick.
  • Kwon YS; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick; Department of Biostatistics, Rutgers School of Public Health, Piscataway, New Jersey.
  • Kim S; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick; Department of Biostatistics, Rutgers School of Public Health, Piscataway, New Jersey.
  • Han CS; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick.
  • Farber N; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick.
  • Kim J; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick.
  • Byun SS; Department of Urology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim WJ; Department of Urology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
  • Jeon SS; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: seongsoo.jeon@samsung.com.
  • Kim IY; Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick. Electronic address: kimiy@cinj.rutgers.edu.
J Urol ; 195(5): 1464-1470, 2016 May.
Article en En | MEDLINE | ID: mdl-26608903
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Próstata / Prostatectomía / Neoplasias de la Próstata / Antígeno Prostático Específico / Estadificación de Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: J Urol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Próstata / Prostatectomía / Neoplasias de la Próstata / Antígeno Prostático Específico / Estadificación de Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: J Urol Año: 2016 Tipo del documento: Article